NCT03762499

Brief Summary

HyperEcho is a multi-centre longitudinal observational study, to investigate whether baseline transthoracic echocardiography along with routine data collected in the hypertension clinic can guide clinicians to better manage, and improve risk stratification for cardiovascular disease in young adults with hypertension. Participants are characterised as young adult patients aged between 18 to 40 years old and referred to the hypertension clinic to manage their blood pressure. The study visit will be carried out during the planned routine visit of the participants to the hypertension clinics of NHS trusts within England. Routine data will be collected by the assigned nurse for the hypertension clinic as part of the clinical service, and research participation will not affect the clinical progress of the participant. The additional research component to the clinic will be asking the participants for their consent to undergo a research echocardiography scan if it has not been a part of their clinical assessment. Participants will also be asked to consent to the use of their data that has been collected in the hypertension clinic, such as; referral letters, medical history, 24-hour blood pressure monitoring report, ECG, blood samples, body fat composition, and dietary questionnaire. In addition to this, participants will be asked to consent to further review of their data and medical notes during their follow up visits (up to 10 years).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
148mo left

Started Oct 2018

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Oct 2018Aug 2038

Study Start

First participant enrolled

October 2, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 6, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 3, 2018

Completed
9.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2038

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

9.8 years

First QC Date

November 6, 2018

Last Update Submit

April 28, 2026

Conditions

Keywords

Young adultsEchocardiography

Outcome Measures

Primary Outcomes (1)

  • Identification of patient clusters based on echocardiographic and clinical findings

    Number of hypertension patient clusters based on echocardiographic and clinical findings

    Obtained at the first clinical visit

Study Arms (2)

Prospective participants

ACTIVE COMPARATOR

250 participants will be recruited prospectively during the hypertension clinic, where a full set of data will be collected from each participant as part of their standard hypertension clinical service. An additional echocardiography scan will be performed for this cohort by the study team, if the scan has not been performed as a part of the clinical care service

Diagnostic Test: Echocardiography scan

Retrospective participants

NO INTERVENTION

500 participants will be recruited retrospectively, and no additional echocardiography scan will be required for them.

Interventions

Echocardiography scanDIAGNOSTIC_TEST

Non-invasive ultrasound imaging of the heart.

Prospective participants

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, aged 18 - 40 years (at the time of their appointment at the hypertension clinic).
  • Referred for a Hypertension Clinic in England.

You may not qualify if:

  • Unable or unwilling to give valid consent for participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiovascular Clinical Research Facility

Oxford, OX3 9DU, United Kingdom

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2018

First Posted

December 3, 2018

Study Start

October 2, 2018

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2038

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Locations